Covaxin: Unpardonable Lies under RTI by CDSCO
In what can be termed as a brutal assault on the Right to Information (RTI) Act, the Central Drug Standard Control Organisation (CDSCO), which is the nodal authority for drug clearance, says it has no information on the World Health Organisation’s (WHO) suspension of the supply of Covaxin (Bharat Biotech) after the latter’s inspection between 14th–22 March 2022 had identified deficiencies in good manufacturing practices (GMP).
Source: moneylife.in